Education
About Us
Working with TipRanks
Follow Us
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY
SHTDY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.30 - $15.16
Previous CloseN/A
Volume2.10K
Average Volume (3M)2.71K
Market Cap
$7.47B
Enterprise Value$75.22B
Total Cash (Recent Filing)$43.33B
Total Debt (Recent Filing)¥101.06B
Price to Earnings (P/E)7.6
Beta0.28
Next Earnings
Sep 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 17, 2025Dividend Yield0.34%
Share Statistics
EPS (TTM)N/A
Shares Outstanding268,362,150
10 Day Avg. Volume0
30 Day Avg. Volume2,715
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.67
Price to Sales (P/S)0.00
P/FCF Ratio5.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$13.00Price Target Upside8.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Sinopharm Group Co News
PremiumCompany Announcements
Sinopharm Group Reports Stable Earnings Amid Revenue Dip
PremiumCompany Announcements
Sinopharm Group Reports Decline in 2024 Earnings
PremiumCompany Announcements
Sinopharm Group Reports Mixed Financial ResultsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
SHTDY FAQ
What was Sinopharm Group Co’s price range in the past 12 months?
Sinopharm Group Co lowest stock price was $10.30 and its highest was $15.16 in the past 12 months.
What is Sinopharm Group Co’s market cap?
Sinopharm Group Co’s market cap is $7.47B.
When is Sinopharm Group Co’s upcoming earnings report date?
Sinopharm Group Co’s upcoming earnings report date is Sep 01, 2025 which is in 40 days.
How were Sinopharm Group Co’s earnings last quarter?
Currently, no data Available
Is Sinopharm Group Co overvalued?
According to Wall Street analysts Sinopharm Group Co’s price is currently Undervalued.
Does Sinopharm Group Co pay dividends?
Sinopharm Group Co pays a Annually dividend of $0.471 which represents an annual dividend yield of 0.34%. See more information on Sinopharm Group Co dividends here
What is Sinopharm Group Co’s EPS estimate?
Sinopharm Group Co’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sinopharm Group Co have?
Sinopharm Group Co has 268,362,150 shares outstanding.
What happened to Sinopharm Group Co’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sinopharm Group Co?
Currently, no hedge funds are holding shares in SHTDY
Sinopharm Group Co Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.94%
12-Months-Change
Fundamentals
Return on Equity
9.19%
Trailing 12-Months
Asset Growth
-0.45%
Trailing 12-Months
Company Description
Sinopharm Group Co
Sinopharm Group Co., Ltd. (SHTDY) is a leading healthcare company based in China, operating primarily in the pharmaceutical distribution, pharmaceutical retail, and medical device sectors. As a comprehensive healthcare service provider, Sinopharm distributes a wide range of pharmaceutical products, traditional Chinese medicines, medical devices, and healthcare products. The company also operates a large network of retail pharmacies and is involved in the research and development of new drugs and medical technologies.